Viewing Study NCT07178795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2026-05-07 @ 5:43 AM
Study NCT ID: NCT07178795
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2025-09-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-squamous Non-small Cell Lung Cancer View
Keywords: